- Location: Virtual
- Date: Thursday 4th March 2021
Held virtually, the afternoon session will feature 2 presentations on hot topics that ran throughout 2020 and what lessons can we learn:
There was much speculation around the impact of Brexit on the pharmaceutical industry. Now that Brexit has finally happened, what changes have we actually seen, particularly with regards to deal-making in the healthcare sector?
The COVID-19 pandemic was a call to arms for the pharmaceutical and biotechnology industries and academia. The unprecedented demand for effective vaccines put enormous pressure on forming successful partnerships. What can we learn from the deals that were negotiated?
More details about this event will be announced in the coming weeks, please check back shortly or contact Adam Collins, firstname.lastname@example.org, for more details
|GMT||Timings subject to change|
|4pm||Welcome & Introduction|
|4.05pm||Impact of Brexit on deal-making in the healthcare sector|
|4.45pm||What can we learn from the deals that were negotiated during the COVID-19 pandemic?|